https://www.insitro.com | United States | 2018 | $643M
Insitro is a data-driven drug discovery and development company based in the United States that leverages machine learning and high-throughput biology. The company’s platform integrates in vitro cellular data and human clinical data to identify therapeutic insights and interventions across diseases, focusing on neuroscience, oncology, and metabolism. Founded in 2018 by CEO Daphne Koller, Insitro is backed by venture capital investors.
